Halberd Corporation (HALB)

USD 0.0

(-8.33%)

Revenue Summary of Halberd Corporation

  • Halberd Corporation's latest annual revenue in 2024 was 999.00 USD , down -63.34% from previous year.
  • Halberd Corporation's latest quarterly revenue in 2024 Q4 was - USD , down 0.0% from previous quarter.
  • Halberd Corporation reported a annual revenue of 2725.00 USD in annual revenue 2023, down -66.02% from previous year.
  • Halberd Corporation reported a annual revenue of 8020.00 USD in annual revenue 2022, up 53.11% from previous year.
  • Halberd Corporation reported a quarterly revenue of - USD for 2024 Q4, down 0.0% from previous quarter.
  • Halberd Corporation reported a quarterly revenue of 834.00 USD for 2024 Q2, up 405.45% from previous quarter.

Annual Revenue Chart of Halberd Corporation (2024 - 2008)

Historical Annual Revenue of Halberd Corporation (2024 - 2008)

Year Revenue Revenue Growth
2024 999.00 USD -63.34%
2023 2725.00 USD -66.02%
2022 8020.00 USD 53.11%
2021 5238.00 USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD -100.0%
2017 151.22 Thousand USD -8.06%
2016 164.48 Thousand USD 0.0%
2008 7015.00 USD 0.0%

Peer Revenue Comparison of Halberd Corporation

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD 98.681%
Evofem Biosciences, Inc. 18.21 Million USD 99.995%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.999%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 99.948%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.994%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD 94.331%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.995%
Intellipharmaceutics International Inc. 65.72 Thousand USD 98.48%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 99.983%
Marizyme, Inc. 645.81 Thousand USD 99.845%
Genus plc 668.8 Million USD 100.0%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 100.0%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 98.991%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 99.756%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 98.699%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD 97.472%
MultiCell Technologies, Inc. 49.32 USD -1925.547%
ONE Bio Corp. 52.29 Million USD 99.998%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.998%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD 97.957%
Q BioMed Inc. 284.35 Thousand USD 99.649%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.997%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.999%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 99.821%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD 98.573%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 99.848%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Enzolytics Inc. 52.79 Thousand USD 98.108%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 99.836%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 100.0%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 99.288%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 99.838%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 100.0%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 99.9%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.998%
BioStem Technologies, Inc. 16.68 Million USD 99.994%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 99.578%
Regen BioPharma, Inc. 236.56 Thousand USD 99.578%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 99.927%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 99.789%
SYBLEU INC 11.69 Thousand USD 91.459%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 99.987%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD 92.315%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD 97.473%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 99.97%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 99.985%
IntelGenx Technologies Corp. 1.03 Million USD 99.904%
Gelesis Holdings, Inc. 25.76 Million USD 99.996%
CSL Limited 14.8 Billion USD 100.0%
Cellectis S.A. 755 Thousand USD 99.868%